Center for Healthcare Organization and Implementation Research (CHOIR)
医疗保健组织和实施研究中心 (CHOIR)
基本信息
- 批准号:9076143
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-10-01 至 2018-09-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse eventAreaBostonCaringCommunicationEnsureEnvironmental HealthEvidence based practiceFamilyGenerationsGenomicsGoalsHealthHealth CommunicationHealth ServicesHealth Services ResearchHealth behavior changeHealthcareHealthcare SystemsHomelessnessInterventionKnowledgeLong-Term CareMeasurableMental HealthMental Health ServicesNew EnglandOutcomePatient CarePatientsPerceptionPharmaceutical PreparationsProviderPublic HealthRecoveryResearchResearch PersonnelRiskScienceSelf ManagementServicesSustainable DevelopmentSystemTrainingTrustVeteransVeterans HospitalsVulnerable PopulationsWorkbasecostempoweredevidence baseimplementation researchimplementation scienceimprovedinnovationmHealthmedical specialtiespatient orientedpatient safetypharmacy benefitprogramspublic health prioritiessocialtherapy developmenttool
项目摘要
DESCRIPTION (provided by applicant):
The Center for Healthcare Organization and Implementation Research (CHOIR) is an HSR&D Center of Innovation (COIN) dedicated to improving Veterans' health outcomes by developing, studying, and applying evidence-based practices that will be widely implemented and sustained. CHOIR builds on two long-standing and highly successful HSR&D Centers of Excellence based at the Bedford VA Hospital and the VA Boston Healthcare System. In partnership with key VA stakeholders, including VA New England Healthcare System (VISN 1), the Office of Patient Care Services-Mental Health Services, the National Center on Homelessness Among Veterans, Pharmacy Benefits Management Service, and the Office of Public Health, we propose to focus our research on three critical areas: 1. Enhancing Recovery-Oriented Care for Behaviorally Vulnerable Populations. We intend to enhance the transformation of VA to a recovery-oriented healthcare system, and to improve recovery-oriented outcomes for behaviorally vulnerable Veterans. Our strategy involves investigators working to address a knowledge gap in operational definitions, build a scientific basis for implementing high-priority program rollouts, and adapt existing interventional evidence for use with this behaviorally vulnerable population. 2. Medication Optimization Program. Providing optimal medication treatment to Veteran patients encompasses many VA priorities regarding safer, more effective, more patient-centered, and more cost-efficient prescriptive practices. Existing tools allow some ability to ensure medication optimization for patients. However, important gaps remain. We will address these gaps by examining how and why medication therapy is prescribed, estimating beneficial and harmful outcomes of medication therapy, and developing and evaluating implementation strategies to promote higher-quality use of medication therapies. 3. Public Health Communication (PHC). Traditional and emerging media and messaging may be used to deliver and exchange information about VA system-wide public health priorities to Veterans both inside and outside of VA care. These priorities include large-scale adverse events, deployment environmental health risks, and health behavior change. An important gap remains regarding best practices in communicating information that maximizes Veterans' trust in VA care, minimizes perceptions of potential harm, and encourages Veterans' self-management. We will work to provide an evidence base and tools for communicating about a range of public health issues, utilizing optimal communication channels such as social media and mobile health platforms, to create effective messaging that empowers Veterans to prioritize their health. CHOIR research will be performed in other areas including organization science, implementation science, long-term care, patient safety, health services genomics and patient-centered communication. We are also fully committed to training a new generation of health services researchers, emphasizing capabilities in developing and conducting research with operational partners, and collaborating with other investigators throughout VA. Through these activities, we intend to move science into practice and to facilitate organizational adaptation to sustain science-based gains for Veterans throughout all levels of the VA healthcare system.
描述(由申请人提供):
医疗保健组织和实施研究中心(CHOIR)是一个HSR&D创新中心(COIN),致力于通过开发,研究和应用将被广泛实施和持续的循证实践来改善退伍军人的健康结果。合唱团建立在两个长期和非常成功的HSR&D卓越中心的基础上,在贝德福德弗吉尼亚州医院和弗吉尼亚州波士顿医疗保健系统。在与关键的VA利益相关者,包括VA新英格兰医疗保健系统(VISN 1),病人护理服务-心理健康服务,退伍军人无家可归的国家中心,药房福利管理服务办公室和公共卫生办公室的伙伴关系,我们建议把我们的研究集中在三个关键领域: 1.加强对行为弱势群体的康复护理。我们打算加强退伍军人事务部向以恢复为导向的医疗保健系统的转变,并改善行为脆弱的退伍军人的恢复导向的结果。我们的战略涉及研究人员努力解决操作定义中的知识差距,为实施高优先级计划的推出建立科学基础,并调整现有的干预证据,以用于这一行为脆弱人群。 2.药物优化计划。为退伍军人患者提供最佳药物治疗包括许多VA优先事项,涉及更安全,更有效,更以患者为中心,更具成本效益的处方实践。现有的工具允许一定的能力,以确保患者的药物优化。 然而,仍然存在重大差距。我们将通过研究如何以及为什么药物治疗是规定的,估计药物治疗的有益和有害的结果,并制定和评估实施战略,以促进更高质量的使用药物治疗来解决这些差距。 3.公共卫生传播。传统和新兴媒体和信息可以用来提供和交流有关VA全系统的公共卫生优先事项的信息,退伍军人内外VA护理。这些优先事项包括大规模不良事件、部署环境健康风险和健康行为改变。一个重要的差距仍然是最佳做法,在沟通信息,最大限度地提高退伍军人的信任在VA护理,最大限度地减少对潜在伤害的看法,并鼓励退伍军人的自我管理。我们将努力提供一个证据基础和工具,用于沟通一系列公共卫生问题,利用社交媒体和移动的健康平台等最佳沟通渠道,创建有效的信息,使退伍军人能够优先考虑他们的健康。 合唱团的研究将在其他领域进行,包括组织科学,实施科学,长期护理,病人安全,健康服务基因组学和以病人为中心的沟通。我们还完全致力于培训新一代的卫生服务研究人员,强调开发和开展研究与业务合作伙伴的能力,并与整个VA的其他调查人员合作。通过这些活动,我们打算将科学付诸实践,并促进组织适应,以维持整个VA医疗保健系统各级退伍军人的科学为基础的收益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAN R. BERLOWITZ其他文献
DAN R. BERLOWITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAN R. BERLOWITZ', 18)}}的其他基金
PRESSURE ULCER RATES IN DESCRIBING NURSING HOME QUALITY
描述疗养院质量的压疮发生率
- 批准号:
2901411 - 财政年份:1998
- 资助金额:
-- - 项目类别:
PRESSURE ULCER RATES IN DESCRIBING NURSING HOME QUALITY
描述疗养院质量的压疮发生率
- 批准号:
2662346 - 财政年份:1998
- 资助金额:
-- - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
-- - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
-- - 项目类别:














{{item.name}}会员




